Background: Cancer-specific survival (CSS) within high-risk non-metastatic prostate cancer varies dramatically. It is likely that within this heterogenous population there are subgroup(s) at extraordinary risk, burdened with an exaptational poor prognosis. Establishing the characteristics of these group(s) would have significant clinical implications since high quality preoperative risk stratification remains the cornerstone of therapeutic decision making to date. Objective: To stratify high-risk prostate cancer based on preoperative characteristics and evaluate cancer specific survival after radical prostatectomy. Method: The EMPaCT multi-center database offers an international population of non-metastatic high-risk prostate cancer. Preope...
BACKGROUND The value of radical prostatectomy (RP) as an approach for very high-risk prostate can...
Purpose: Lymph node positive (pN+) prostate cancer after radical prostatectomy has wide variability ...
<p>Patients with high-risk prostate cancer (PC) make up a heterogeneous population who has a substan...
Background: Cancer-specific survival (CSS) within high-risk non-metastatic prostate cancer varies dr...
BACKGROUND: High-risk prostate cancer (PCa) is an extremely heterogeneous disease. A clear definitio...
BACKGROUND High-risk prostate cancer (PCa) is an extremely heterogeneous disease. A clear definit...
Current National Comprehensive Cancer Network guidelines recommend postoperative radiation therapy b...
BACKGROUND:Current National Comprehensive Cancer Network guidelines recommend postoperative radiatio...
ava i lable at www.sciencedirect.com journal homepage: www.europeanurology.com prognosis subgroup (G...
PURPOSE: To assess survival and competing causes of mortality in prostate cancer (PCa) patients ref...
Objective: The aim of this study was to assess the surgical outcome of high-grade prostate cancer (P...
Background Risk prediction models that incorporate biomarkers and clinicopathologic variables may be...
Introduction & Objectives: Several studies have shown that the outcome of high risk prostate cancer ...
BackgroundRisk prediction models that incorporate biomarkers and clinicopathologic variables may be ...
Despite the key importance of magnetic resonance imaging (MRI) parameters, risk classification syste...
BACKGROUND The value of radical prostatectomy (RP) as an approach for very high-risk prostate can...
Purpose: Lymph node positive (pN+) prostate cancer after radical prostatectomy has wide variability ...
<p>Patients with high-risk prostate cancer (PC) make up a heterogeneous population who has a substan...
Background: Cancer-specific survival (CSS) within high-risk non-metastatic prostate cancer varies dr...
BACKGROUND: High-risk prostate cancer (PCa) is an extremely heterogeneous disease. A clear definitio...
BACKGROUND High-risk prostate cancer (PCa) is an extremely heterogeneous disease. A clear definit...
Current National Comprehensive Cancer Network guidelines recommend postoperative radiation therapy b...
BACKGROUND:Current National Comprehensive Cancer Network guidelines recommend postoperative radiatio...
ava i lable at www.sciencedirect.com journal homepage: www.europeanurology.com prognosis subgroup (G...
PURPOSE: To assess survival and competing causes of mortality in prostate cancer (PCa) patients ref...
Objective: The aim of this study was to assess the surgical outcome of high-grade prostate cancer (P...
Background Risk prediction models that incorporate biomarkers and clinicopathologic variables may be...
Introduction & Objectives: Several studies have shown that the outcome of high risk prostate cancer ...
BackgroundRisk prediction models that incorporate biomarkers and clinicopathologic variables may be ...
Despite the key importance of magnetic resonance imaging (MRI) parameters, risk classification syste...
BACKGROUND The value of radical prostatectomy (RP) as an approach for very high-risk prostate can...
Purpose: Lymph node positive (pN+) prostate cancer after radical prostatectomy has wide variability ...
<p>Patients with high-risk prostate cancer (PC) make up a heterogeneous population who has a substan...